Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SRx Health Solutions (SRXH) Profit After Tax (2016 - 2025)

Historic Profit After Tax for SRx Health Solutions (SRXH) over the last 16 years, with Q2 2025 value amounting to -$15.1 million.

  • SRx Health Solutions' Profit After Tax fell 38581.06% to -$15.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$18.6 million, marking a year-over-year increase of 1667.49%. This contributed to the annual value of $4.2 million for FY2024, which is 11841.02% up from last year.
  • According to the latest figures from Q2 2025, SRx Health Solutions' Profit After Tax is -$15.1 million, which was down 38581.06% from -$964000.0 recorded in Q1 2025.
  • SRx Health Solutions' 5-year Profit After Tax high stood at $24.8 million for Q2 2021, and its period low was -$24.4 million during Q4 2022.
  • Moreover, its 5-year median value for Profit After Tax was -$3.7 million (2023), whereas its average is -$4.6 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first soared by 23462.29% in 2021, then tumbled by 38581.06% in 2025.
  • Over the past 5 years, SRx Health Solutions' Profit After Tax (Quarter) stood at -$5.1 million in 2021, then tumbled by 379.28% to -$24.4 million in 2022, then soared by 39.66% to -$14.7 million in 2023, then surged by 72.91% to -$4.0 million in 2024, then tumbled by 279.94% to -$15.1 million in 2025.
  • Its last three reported values are -$15.1 million in Q2 2025, -$964000.0 for Q1 2025, and -$4.0 million during Q4 2024.